Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Vaccine
|
May 21, 2025
DNA co-delivery of seasonal H1 influenza hemagglutinin nanoparticle vaccines with chemokine adjuvant CTACK induces potent immunogenicity for heterologous protection in vivo
Kevin Liaw, Kylie M Konrath, Abigail R Trachtman, et al.
Vaccine
|
April 16, 2022
Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates
Jewell N Walters, Blake Schouest, Ami Patel, et al.
Frontiers in Immunology
|
March 31, 2023
Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge
Ebony N Gary, Nicholas J Tursi, Bryce M Warner, et al.
Iscience
|
June 14, 2021
A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens
Ebony N Gary, Bryce M Warner, Elizabeth M Parzych, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 14, 2021
Debulking SARS-CoV-2 in saliva using angiotensin converting enzyme 2 in chewing gum to decrease oral virus transmission and infection
Henry Daniell, Smruti K Nair, Nardana Esmaeili, et al.
Emerging Microbes & Infections
|
January 2, 2024
In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primates
Ami Patel, Kyle Rosenke, Elizabeth M Parzych, et al.
Cell Reports. Medicine
|
March 22, 2025
Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunity
Nicholas J Tursi, Sachchidanand Tiwari, Nicole Bedanova, et al.
Nature Communications
|
January 8, 2025
Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers
Christian J Maine, Shigeki J Miyake-Stoner, Darina S Spasova, et al.
Nature Communications
|
October 6, 2022
DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2
Elizabeth M Parzych, Jianqiu Du, Ali R Ali, et al.
Plos Pathogens
|
February 19, 2026
Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization
Kylie M Konrath, Kevin Liaw, Nicholas J Tursi, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Vaccine
|
May 21, 2025
DNA co-delivery of seasonal H1 influenza hemagglutinin nanoparticle vaccines with chemokine adjuvant CTACK induces potent immunogenicity for heterologous protection in vivo
Kevin Liaw, Kylie M Konrath, Abigail R Trachtman, et al.
Vaccine
|
April 16, 2022
Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates
Jewell N Walters, Blake Schouest, Ami Patel, et al.
Frontiers in Immunology
|
March 31, 2023
Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge
Ebony N Gary, Nicholas J Tursi, Bryce M Warner, et al.
Iscience
|
June 14, 2021
A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens
Ebony N Gary, Bryce M Warner, Elizabeth M Parzych, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 14, 2021
Debulking SARS-CoV-2 in saliva using angiotensin converting enzyme 2 in chewing gum to decrease oral virus transmission and infection
Henry Daniell, Smruti K Nair, Nardana Esmaeili, et al.
Emerging Microbes & Infections
|
January 2, 2024
In vivo delivery of engineered synthetic DNA-encoded SARS-CoV-2 monoclonal antibodies for pre-exposure prophylaxis in non-human primates
Ami Patel, Kyle Rosenke, Elizabeth M Parzych, et al.
Cell Reports. Medicine
|
March 22, 2025
Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunity
Nicholas J Tursi, Sachchidanand Tiwari, Nicole Bedanova, et al.
Nature Communications
|
January 8, 2025
Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers
Christian J Maine, Shigeki J Miyake-Stoner, Darina S Spasova, et al.
Nature Communications
|
October 6, 2022
DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2
Elizabeth M Parzych, Jianqiu Du, Ali R Ali, et al.
Plos Pathogens
|
February 19, 2026
Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization
Kylie M Konrath, Kevin Liaw, Nicholas J Tursi, et al.
Page
of 4